Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors engaged.

The illicit trade of fake medicines is a “growing threat” in Europe, EU’s law enforcement agency warned today. There is a rise in the trade of either sub-standard, falsely labelled or falsified ...